TY  - GENERIC
DO  - 10.20944/preprints202103.0113.v1
UR  - http://dx.doi.org/10.20944/preprints202103.0113.v1
TI  - Viewpoint: The Current Advances and Future Optimization of Blood-based Tumor Mutation Burden as a Biomarker for Cancer Immunotherapy
T2  - Preprints
AU  - Li, Anlin
PY  - 2021
DA  - 2021/03/02
PB  - Preprints